 |
The Journal of Neuroscience, January 7, 2004, 24(1):269-281; doi:10.1523/JNEUROSCI.1409-03.2004
Previous Article | Next Article 
Neurobiology of Disease
Huntingtin Bodies Sequester Vesicle-Associated Proteins by a Polyproline-Dependent Interaction
Zheng-Hong Qin,1
Yumei Wang,1
Ellen Sapp,1
Benjamin Cuiffo,1
Erich Wanker,3
Michael R. Hayden,4
Kimberly B. Kegel,1
Neil Aronin,2 and
Marian DiFiglia1
1Laboratory of Cellular Neurobiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, 2Departments of Medicine and Cell Biology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, 3Max-Planck-Institut for Molecular Genetics, D-14195 Berlin, Germany, and 4Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada
Polyglutamine expansion in the N terminus of huntingtin (htt) causes selective neuronal dysfunction and cell death by unknown mechanisms. Truncated htt expressed in vitro produced htt immunoreactive cytoplasmic bodies (htt bodies). The fibrillar core of the mutant htt body resisted protease treatment and contained cathepsin D, ubiquitin, and heat shock protein (HSP) 40. The shell of the htt body was composed of globules 14-34 nm in diameter and was protease sensitive. HSP70, proteasome, dynamin, and the htt binding partners htt interacting protein 1 (HIP1), SH3-containing Grb2-like protein (SH3GL3), and 14.7K-interacting protein were reduced in their normal location and redistributed to the shell. Removal of a series of prolines adjacent to the polyglutamine region in htt blocked formation of the shell of the htt body and redistribution of dynamin, HIP1, SH3GL3, and proteasome to it. Internalization of transferrin was impaired in cells that formed htt bodies. In cortical neurons of Huntington's disease patients with early stage pathology, dynamin immunoreactivity accumulated in cytoplasmic bodies. Results suggest that accumulation of a nonfibrillar form of mutant htt in the cytoplasm contributes to neuronal dysfunction by sequestering proteins involved in vesicle trafficking.
Key words: Huntington's disease; huntingtin; autophagy; vesicle trafficking; dynamin; protein aggregates; protein interactions
Received May 9, 2003;
revised October 1, 2003;
accepted October 20, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
R. S. Atwal, J. Xia, D. Pinchev, J. Taylor, R. M. Epand, and R. Truant
Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity
Hum. Mol. Genet.,
November 1, 2007;
16(21):
2600 - 2615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rockabrand, N. Slepko, A. Pantalone, V. N. Nukala, A. Kazantsev, J. L. Marsh, P. G. Sullivan, J. S. Steffan, S. L. Sensi, and L. M. Thompson
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis
Hum. Mol. Genet.,
January 1, 2007;
16(1):
61 - 77.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M. Olkkonen and E. Ikonen
When intracellular logistics fails - genetic defects in membrane trafficking
J. Cell Sci.,
December 15, 2006;
119(24):
5031 - 5045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dehay and A. Bertolotti
Critical Role of the Proline-rich Region in Huntingtin for Aggregation and Cytotoxicity in Yeast
J. Biol. Chem.,
November 24, 2006;
281(47):
35608 - 35615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Duennwald, S. Jagadish, P. J. Muchowski, and S. Lindquist
Flanking sequences profoundly alter polyglutamine toxicity in yeast
PNAS,
July 18, 2006;
103(29):
11045 - 11050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al.
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity.
J. Neurosci.,
April 26, 2006;
26(17):
4649 - 4659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Matsumoto, S. Kim, and R. I. Morimoto
Huntingtin and Mutant SOD1 Form Aggregate Structures with Distinct Molecular Properties in Human Cells
J. Biol. Chem.,
February 17, 2006;
281(7):
4477 - 4485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ralser, U. Nonhoff, M. Albrecht, T. Lengauer, E. E. Wanker, H. Lehrach, and S. Krobitsch
Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways
Hum. Mol. Genet.,
October 1, 2005;
14(19):
2893 - 2909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Hay, K. Sathasivam, S. Tobaben, B. Stahl, M. Marber, R. Mestril, A. Mahal, D. L. Smith, B. Woodman, and G. P. Bates
Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach
Hum. Mol. Genet.,
July 1, 2004;
13(13):
1389 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|